These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36059929)

  • 41. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
    Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional annotation of uncharacterized proteins from Fusobacterium nucleatum: identification of virulence factors.
    Rauthan K; Joshi S; Kumar L; Goel D; Kumar S
    Genomics Inform; 2023 Jun; 21(2):e21. PubMed ID: 37415454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
    Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
    Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha-1 antitrypsin is markedly decreased following pulmonary F. tularensis challenge.
    Chambers JP; Yu JJ; Jupelli M; Weintraub ST; Lopez-Ribot JL; Valdes JJ; Arulanandam BP
    Front Cell Infect Microbiol; 2011; 1():20. PubMed ID: 22919586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction of a Francisella tularensis two-dimensional electrophoresis protein database.
    Hernychová L; Stulík J; Halada P; Macela A; Kroca M; Johansson T; Malina M
    Proteomics; 2001 Apr; 1(4):508-15. PubMed ID: 11681204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
    Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The complete genome sequence of Francisella tularensis, the causative agent of tularemia.
    Larsson P; Oyston PC; Chain P; Chu MC; Duffield M; Fuxelius HH; Garcia E; Hälltorp G; Johansson D; Isherwood KE; Karp PD; Larsson E; Liu Y; Michell S; Prior J; Prior R; Malfatti S; Sjöstedt A; Svensson K; Thompson N; Vergez L; Wagg JK; Wren BW; Lindler LE; Andersson SG; Forsman M; Titball RW
    Nat Genet; 2005 Feb; 37(2):153-9. PubMed ID: 15640799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of an essential Francisella tularensis subsp. tularensis virulence factor.
    Qin A; Scott DW; Thompson JA; Mann BJ
    Infect Immun; 2009 Jan; 77(1):152-61. PubMed ID: 18981253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of a wild-type strain of Francisella tularensis isolated from a cat.
    Inzana TJ; Glindemann GE; Snider G; Gardner S; Crofton L; Byrne B; Harper J
    J Vet Diagn Invest; 2004 Sep; 16(5):374-81. PubMed ID: 15460318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Francisella tularensis pilin homologs on pilus formation and virulence.
    Ark NM; Mann BJ
    Microb Pathog; 2011 Sep; 51(3):110-20. PubMed ID: 21605655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist.
    Walters KA; Olsufka R; Kuestner RE; Wu X; Wang K; Skerrett SJ; Ozinsky A
    BMC Genomics; 2015 Oct; 16():874. PubMed ID: 26510639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using host-pathogen protein interactions to identify and characterize Francisella tularensis virulence factors.
    Wallqvist A; Memišević V; Zavaljevski N; Pieper R; Rajagopala SV; Kwon K; Yu C; Hoover TA; Reifman J
    BMC Genomics; 2015 Dec; 16():1106. PubMed ID: 26714771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel broth medium for enhanced growth of Francisella tularensis.
    Morris BJ; Buse HY; Adcock NJ; Rice EW
    Lett Appl Microbiol; 2017 Jun; 64(6):394-400. PubMed ID: 28255998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Determination of the Subspecies of Francisella tularensis Isolated in Turkey by Molecular Methods].
    Çelebi B; Bakkaloğlu Z; Ünaldı Ö; Karagöz A; Kılıç S; Durmaz R
    Mikrobiyol Bul; 2020 Jan; 54(1):1-10. PubMed ID: 32050874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
    Fulop M; Mastroeni P; Green M; Titball RW
    Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The subversion of the immune system by francisella tularensis.
    Bosio CM
    Front Microbiol; 2011; 2():9. PubMed ID: 21687406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct repeat-mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis.
    Forslund AL; Kuoppa K; Svensson K; Salomonsson E; Johansson A; Byström M; Oyston PC; Michell SL; Titball RW; Noppa L; Frithz-Lindsten E; Forsman M; Forsberg A
    Mol Microbiol; 2006 Mar; 59(6):1818-30. PubMed ID: 16553886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosome rearrangement and diversification of Francisella tularensis revealed by the type B (OSU18) genome sequence.
    Petrosino JF; Xiang Q; Karpathy SE; Jiang H; Yerrapragada S; Liu Y; Gioia J; Hemphill L; Gonzalez A; Raghavan TM; Uzman A; Fox GE; Highlander S; Reichard M; Morton RJ; Clinkenbeard KD; Weinstock GM
    J Bacteriol; 2006 Oct; 188(19):6977-85. PubMed ID: 16980500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W
    Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine.
    Karlsson J; Prior RG; Williams K; Lindler L; Brown KA; Chatwell N; Hjalmarsson K; Loman N; Mack KA; Pallen M; Popek M; Sandström G; Sjöstedt A; Svensson T; Tamas I; Andersson SG; Wren BW; Oyston PC; Titball RW
    Microb Comp Genomics; 2000; 5(1):25-39. PubMed ID: 11011763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.